This exciting development allows us to understand the contribution of serum FABP4 to metabolic diseases in the context of peripheral tissues and develop a greater understanding of how targeting circulating FABP4 may be used clinically for the prevention or treatment of immunometabolic diseases. Here, FABP4 is linked to metabolic disease.